Pharma, Biotech and Generics Industry News | The Pharmaletter
2025年1月2日 · In some good news for the US vaccines developer, whose stock has fallen 66% in the past 12 months, Moderna on Friday announced ongoing support from the US …
US FDA warning over counterfeit drugs bought in Mexico
2005年5月15日 · The US Food and Drug Administration is warning the public about the sale of counterfeit versions of Pfizer's Lipitor (atorvastatin) and Viagra (sildenafil), and an unapproved …
Pharma USA 2025 - The Pharmaletter
The two day event offers a variety of means for networking and collaboration: Hackathons offering a hyper-interactive session where attendees work as a team to hack strategic issues.
Eisai announces launch of Rozebalamin and Tasfygo
2024年11月21日 · Japanese drugmaker Eisai (TYO: 4523)has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched …
Viatris faces FDA import restrictions at Indian facility
2024年12月24日 · Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 products while exempting four for shortages. The …
Citryll raises 85 million euros | The Pharmaletter
2024年12月9日 · Dutch biotech Citryll, which is focused on treating immune-mediated inflammatory diseases by targeting neutrophil extracellular traps (NETs), today announced the …
Concerns about tablet-splitting of muscle relaxant
2004年5月23日 · Back and neck pain sufferers who divide the most frequently-prescribed muscle relaxant may be getting anywhere from half to one-and-a-half times the amount of medicine …
Positive Phase III trials results with BMS’ Sotyktu
2024年12月24日 · US pharma major Bristol Myers Squibb has announced positive results from POETYK PsA-1 (IM011-054) and POETYK PsA-2 (IM011-055), the pivotal Phase III trials …
Autolus Therapeutics announces FDA approval of Aucatzyl
2024年11月11日 · On November 8, the US Food and Drug Administration approved Aucatzyl (obecabtagene autoleucel; obe-cel) from US biopharma Autolus Therapeutics, whose share …
Trump vs Harris—who's on Big Pharma's side? | Pharmaceutical
2024年9月22日 · In the 2024 US presidential election, health policy will remain a key issue for pharma. Both Donald Trump and Kamala Harris have criticized high drug prices, raising …